pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 10·1 min read
save

Boston ER doctor Jeremy Faust grows influence with Inside Medicine newsletter

Jul 10, 2026·read at STAT ↗Positive

Jeremy Faust works as an emergency physician at Brigham and Women's Hospital in Boston, handling busy shifts and caring for dozens of patients.

In addition to his clinical duties, Faust runs the Substack newsletter Inside Medicine, which reaches about 85,000 subscribers and is known for timely medical and news commentary.

Recently he used the platform to break a story about the MV Hondius cruise ship, revealing that 26 passengers had disembarked earlier than previously reported, highlighting his role in rapid information sharing.

His outspoken style has attracted a large following during the politically charged Trump era, positioning him as a prominent voice in both medicine and public discourse.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: How a Boston doctor built a following as a ‘loud and unafraid’ voice in the Trump era”

read at STAT ↗
482 words · retrieved Jul 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Brigham and Women's HospitalUltragenyx Pharmaceutical Inc.
topics
PainRare DiseaseVaccines

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 21Skeptical about modern medicine? I know the feeling — and want to listenSTAT
  • Sep 3FDA Approves First Drug to Treat Alexander Diseasefda press
  • Sep 3Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readoutFierce Biotech
  • Jun 29FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press